MississippiHB 14632025 Regular SessionHouse

Pseudoephedrine; require manufacturers to pay fees to National Association of Drug Diversion Investigators to support NPLE.

Sponsored By: Christopher Bell (Democratic)

Signed by Governor

Drug PolicyPublic Health and Welfare

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

New monthly fees for cold medicine manufacturers

Beginning October 1, 2025, manufacturers must pay monthly fees for pseudoephedrine or ephedrine products sold in or into Mississippi. The fees support the National Precursor Log Exchange, which tracks sales of these medicines. The National Association of Drug Diversion Investigators receives the fees and sets their amounts. Manufacturers must provide written proof of payment when the Mississippi State Board of Pharmacy requests it. The law does not specify fee amounts or any effect on household prices.

Sponsors & Cosponsors

Sponsor

  • Christopher Bell

    Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 168 • No: 1

Senate vote • 3/11/2025

Passed

Yes: 50 • No: 1

House vote • 2/13/2025

Passed

Yes: 118 • No: 0

Actions Timeline

  1. Approved by Governor

    3/18/2025legislature
  2. Enrolled Bill Signed

    3/13/2025Senate
  3. Enrolled Bill Signed

    3/13/2025House
  4. Returned For Enrolling

    3/12/2025Senate
  5. Passed

    3/11/2025Senate
  6. Title Suff Do Pass

    3/3/2025Senate
  7. Referred To Public Health and Welfare

    2/17/2025Senate
  8. Transmitted To Senate

    2/14/2025House
  9. Passed

    2/13/2025House
  10. Read the Third Time

    2/12/2025House
  11. Title Suff Do Pass

    1/30/2025House
  12. Referred To Drug Policy

    1/20/2025House

Bill Text

Related Bills

Back to State Legislation